UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | F | G | H | I | J | K | L | M | N | O | P | R | S | T | V | W | Y
Number of items: 215.

A

Ardeshna, KM; Corney, CP; Ings, SJ; Watts, MJ; Linch, DC; Devereux, S; (1998) Generation of functionally competent antigen presenting cells from CD34+ progenitors suitable for clinical use. BRIT J HAEMATOL , 101 101 - 101.

Ardeshna, KM; Corney, CP; Ings, SJ; Watts, MJ; Linch, DC; Devereux, S; (1998) A clinically applicable method for the ex-vivo generation of antigen presenting cells from CD34+ progenitors. BONE MARROW TRANSPL , 21 S15 - S15.

Ardeshna, KM; Pizzey, AR; Linch, DC; Devereux, S; (1998) Monocyte derived dendritic cells do not proliferate and are refractory to transduction by retroviral vectors. BLOOD , 92 (10) 56B - 57B.

Arguello, JR; Little, AM; Bohan, E; Goldman, JM; Marsh, SGE; Madrigal, JA; (1998) High resolution HLA Class I typing by double strand conformation analysis (DSCA). Tissue Antigens , 52 pp. 57-66.

Arguello, JR; Little, AM; Bohan, E; Goldman, JM; Marsh, SGE; Madrigal, JA; (1998) High resolution HLA class I typing by reference strand mediated conformation analysis (RSCA). TISSUE ANTIGENS , 52 (1) pp. 57-66. 10.1111/j.1399-0039.1998.tb03024.x.

Arguello, JR; Little, AM; Pay, AL; Gallardo, D; Rojas, I; Marsh, SGE; Goldman, JM; (1998) Mutation detection and typing of polymorphic loci through double-strand conformation analysis. NATURE GENETICS , 18 (2) pp. 192-194. 10.1038/ng0298-192.

Arnold, J; Ouwehand, W; Smith, GA; Cohen, H; (1998) Tahini associated thrombocytopenia. In: (Proceedings) British society for haematology annual scientific meeting.

Arnold, J; Ouwehand, WH; Smith, GA; Cohen, H; (1998) A young woman with petechiae. Lancet , 352 (9128) 618-.

Atsumi, T; Khamashta, MA; Amengual, O; Donohoe, S; Mackie, I; Ichikawa, K; Koike, T; (1998) Binding of anticardiolipin antibodies to protein C via beta(2)-glycoprotein I (beta(2)-GPI): a possible mechanism in the inhibitory effect of antiphospholipid antibodies on the protein C system. CLIN EXP IMMUNOL , 112 (2) 325 - 333.

B

Bain, BJ; Moorman, AV; Johansson, B; Mehta, AB; Secker-Walker, LMOBOTEQWP; (1998) Myelodysplastic syndromes associated with 11q23 abnormalities. Leukaemia , 12 pp. 905-913.

Battini, JL; Danos, O; Heard, JM; (1998) Definition of a 14-amino-acid peptide essential for the interaction between the murine leukemia virus amphotropic envelope glycoprotein and its receptor. J Virol , 72 (1) pp. 428-435.

Belkacemi, Y; Labopin, M; Vernant, JP; Prentice, HG; Tichelli, A; Schattenberg, A; Boogaerts, MA; ... Gorin, NC; + view all (1998) Cataracts after total body irradiation and bone marrow transplantation in patients with acute leukemia in complete remission: a study of the European Group for Blood and Marrow Transplantation. International Journal of Radiation Oncology Biology Physics , 41 (3) pp. 659-668.

Bernard, T; Gale, RE; Evans, JPM; Linch, DC; (1998) Mutations of the granulocyte-colony stimulating factor receptor in patients with severe congenital neutropenia are not required for transformation to acute myeloid leukaemia and may be a bystander phenomenon. BRIT J HAEMATOL , 101 (1) 141 - 149.

Bierman, P; Kottaridis, P; Kollath, J; Vose, J; Linch, D; Mackinnon, S; Bishop, M; ... Armitage, J; + view all (1998) Allogeneic transplantation following failure of autologous transplantation for lymphoma. BLOOD , 92 (10) 321A - 321A.

Borthwick, NJ; Yong, KL; Salmon, M; Buckley, C; Akbar, AN; (1998) Transendothelial migration confers a survival advantage to activated T lymphocytes. FASEB JOURNAL , 12 (5) A1055-A1055.

Burnett, AK; Goldstone, AH; Stevens, RM; Hann, IM; Rees, JK; Gray, RG; Wheatley, K; (1998) Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Parties. The Lancet , 351 (9104) pp. 700-708.

C

Cardigan, R; McGloin, H; Mackie, I; Machin, S; Singer, M; (1998) Endothelial dysfunction in critically ill patients: the effect of haemofiltration. INTENS CARE MED , 24 (12) 1264 - 1271.

Cardigan, RA; Donohoe, S; Purdy, G; Mackie, IJ; Machin, SJ; (1998) The association of factor VIIa, factor XIIa and beta(2)-glycoprotein-1 with triglyceride-rich lipoproteins in normolipidaemic subjects. BLOOD COAGUL FIBRIN , 9 (4) 323 - 332.

Cardigan, RA; Donohoe, S; Purdy, G; Mackie, IJ; Machin, SJ; (1998) The association of factor VIIa, factor XIIa and beta2-glycoprotein-1 with triglyceride-rich lipoproteins in normolipidaemic subjects. Blood Coagulation and Fibrinolysis , 9 (4) pp. 323-332.

Chatterjee, R; Katz, M; Oatridge, A; Bydder, GM; Porter, JB; (1998) Selective loss of anterior pituitary volume with severe pituitary-gonadal insufficiency in poorly compliant male thalassemic patients with pubertal arrest. COOLEYS ANEMIA , 850 479 - 482.

Coffin, RS; Thomas, SK; Thomas, NSB; Lilley, CE; Pizzey, AR; Griffiths, CH; Gibb, BJ; ... Latchman, DS; + view all (1998) Populations of transduced primary human cells can be produced using GFP expressing herpes virus vectors and flow cytometry. Gene Therapy , 5 pp. 718-722.

Coffin, RS; Thomas, SK; Thomas, NSB; Lilley, CE; Pizzey, AR; Griffiths, CH; Gibb, BJ; ... Latchman, DS; + view all (1998) Pure populations of transduced primary human cells can be produced using GFP expressing herpes virus vectors and flow cytometry. GENE THER , 5 (5) 718 - 722.

Cohen, H; Holmes, PA; Thomas, DJ; Bydder GM, ; (1998) Asymptomatic cerebral ischaemic lesions in patients with primary Antiphospholipid syndrome. In: (Proceedings) British society for haematology annual scientific meeting.

Cohen, H; Ozanne, C; (1998) Thrombosis. In: Webb, A and Shapiro, MJ and Singer, M and Suter, P, (eds.) Oxford textbook of critical care. Oxford University Press

Cohen, SBA; Dominiguez, E; Lowdell, M; Madrigal, JA; (1998) The immunological properties of cord blood: overview of current research presented at the 2nd EUROCORD Workshop. BONE MARROW TRANSPLANTATION , 22 S22-S25.

Craston, R; Lowdell, MW; Prentice, HG; (1998) The influence of interleukin-2 (IL-2), IL-7 and IL-15 on the development of natural killer cells. BLOOD , 92 (10) 57B - 57B.

Curnow, A; McIlroy, BW; Postle-Hacon, MJ; Porter, JB; MacRobert, AJ; Bown, SG; (1998) Enhancement of 5-aminolaevulinic acid-induced photodynamic therapy in normal rat colon using hydroxypyridinone iron-chelating agents. BRIT J CANCER , 78 (10) 1278 - 1282.

D

Dattani, MT; Martinez-Barbera, JP; Thomas, PQ; Brickman, JM; Gupta, R; Martensson, IL; Toresson, H; ... Robinson, ICAF; + view all (1998) Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. NAT GENET , 19 (2) 125 - 133.

Devereux, H; Sabin, CA; Kinson, Z; Brown, D; Griffioen, A; Dusheiko, GM; Lee, CA; (1998) Influence of HIV-1 infection on GBV-C infection in multiply infected haemophilic patients. J MED VIROL , 56 (4) 316 - 320.

Devereux, S; Corney, C; Macdonald, C; Watts, M; Sullivan, A; Goldstone, AH; Ward, M; ... Linch, DC; + view all (1998) Feasibility of multidrug resistance (MDR-1) gene transfer in patients undergoing high-dose therapy and peripheral blood stem cell transplantation for lymphoma. GENE THER , 5 (3) 403 - 408.

Devereux, S; Linch, DC; (1998) Granulocyte-macrophage colony-stimulating factor. In: Mire-Sluis, A, (ed.) Cytokines. Academic Press: San Diego.

Donohoe, S; Geary, M; Kingdom, J; Hindmarsh, P; Mackie, I; Machin, S; (1998) Prevalence of anti-beta 2-glycoprotein I and anticardiolipin antibodies in 475 pregnancies, with pregnancy outcome. BRIT J HAEMATOL , 102 (1) 248 - 248.

Donohoe, S; Geary, M; Kingdom, J; Hindmarsh, PC; Mackie, I; Machin, S; (1998) Prevalence of anti- 2 GPI IgG and anticardiolipin IgG and IgM in 475 healthy singleton pregnancies: correlation with uteroplacental Doppler and pregnancy outcome. In: (pp. S56-).

Donohoe, S; Geary, M; Kingdom, J; Hindmarsh, PC; Mackie, I; Machin, S; (1998) Prevalence of anti- 2 GPI, anti-prothrombin and anticardiolipin in 1506 pregnancies: association with pregnancy outcome. In: (pp. S192-).

Donohoe, S; Geary, M; Kingdom, J; Jauniaux, E; Hindmarsh, PC; Mackie, I; Machin, S; (1998) Anticardiolipin and anti-   B2 GPI antibodies in pregnancies with abnormal uterine Doppler. In: (pp. S42-).

Donohoe, S; Kingdom, J; Quenby, S; Jauniaux, E; Mackie, I; Machin, S; (1998) Beta-2-glycoprotein and Annexin V in villous placenta during normal and antiphospholipid pregnancies. BRIT J HAEMATOL , 102 (1) 248 - 248.

F

Fanin, R; Silvestri, F; de Elvira, MCR; Taghipour, G; Sperotto, A; Goldstone, AH; (1998) A EBMT survey of 65 cases transplanted for T- and null-cell type CD30 positive anaplastic large cell lymphoma. In: (pp. S170-S170). NATURE PUBLISHING GROUP

Fielding, AK; Maurice, M; Morling, FJ; Cosset, FL; Russell, SJ; (1998) Inverse targeting of retroviral vectors: Selective gene transfer in a mixed population of hematopoietic and nonhematopoietic cells. BLOOD , 91 (5) pp. 1802-1809.

Freeburn, RW; Gale, RE; Linch, DC; (1998) Activating point mutations in the beta(C) chain of the GM-CSF, IL-3 and IL-5 receptors are not a major contributory factor in the pathogenesis of acute myeloid leukaemia. BRIT J HAEMATOL , 103 (1) 66 - 71.

G

Gale, RE; Best, AJ; Pouwels, K; Park, S; Linch, DC; (1998) Multiple alternatively spliced transcripts of SHP-1 are expressed in primary myeloid cells and change with differentiation. BLOOD , 92 (10) 157B - 157B.

Gale, RE; Freeburn, RW; Khwaja, A; Chopra, R; Linch, DC; (1998) A truncated isoform of the human beta chain common to the receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3), and IL-5 with increased mRNA expression in some patients with acute leukemia. BLOOD , 91 (1) 54 - 63.

Gale, RE; Linch, DC; (1998) Clonality studies in acute myeloid leukemia. LEUKEMIA , 12 (2) 117 - 120.

Ganeshagun, K; Hart, SM; Jones, DT; Wickremasinghe, RG; Virchis, AE; Prentice, HG; Man, A; ... Mehta, AB; + view all (1998) Clinical treatment with CGP 41251 increases sensitivity of CLL cells to conventional therapy. BRIT J HAEMATOL , 102 (1) 334 - 334.

Gardiner, C; Chavda, N; Harrison, P; (1998) Characterisation of tryptase positive cells derived from the human Philadelphia positive leukaemia cell line KU812. A model for studying mast cells. Presented at: UNSPECIFIED.

Gardiner, C; Harrison, P; (1998) O13 Platelet aggregation responses to human mast cell activation. Blood Coagulation & Fibrinolysis , 9 (8) p. 775.

Gardiner, C; Mackie, IJ; Machin, SJ; (1998) Simultaneous assay of free and total protein S by ELISA using monoclonal and polyclonal antibodies. CLIN LAB HAEMATOL , 20 (1) 41 - 45.

Gardiner, C; Mackie, IJ; Machin, SJ; (1998) Simultaneous assay of free and total protein S by ELISA using monoclonal and polyclonal antibodies. Clinical and Laboratory Haematology , 20 (1) pp. 41-45. 10.1046/j.1365-2257.1998.00087.x.

Geary, M; Donohoe, S; Kingdom, J; Hindmarsh, PC; Mackie, I; Machin, S; Rodeck, CH; (1998) Prevalence of anti- 2 GP1 IgG and anticardiolipin IgG and IgM in pregnancy: correlation with uterine artery Doppler and pregnancy outcome. In: (pp. p. 77).

Glueck, CJ; Freiberg, R; Crawford, A; Roy, D; Glueck, H; Stroop, D; (1998) To the editor [1] (multiple letters). Journal of Bone and Joint Surgery - Series A , 80 (4) pp. 604-606.

Golay, J; Broccoli, V; Lamorte, G; Bifulco, C; Parravicini, C; Pizzey, A; Thomas, NSB; ... Introna, M; + view all (1998) The A-Myb transcription factor is a marker of centroblasts in vivo. JOURNAL OF IMMUNOLOGY , 160 (6) pp. 2786-2793.

Goldstone, AH; (1998) The case for and against high-dose therapy with stem cell rescue for early poor prognosis Hodgkin's disease in first remission. Annals of Oncology , 9 (5) S83-S85.

Grundy, JE; Lawson, KM; MacCormac, LP; Fletcher, JM; Yong, KL; (1998) Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit virus by direct neutrophil-endothelial cell contact and during neutrophil transendothelial migration. J Infect Dis , 177 (6) pp. 1465-1474. 10.1086/515300.

Gupta, R; Thomas, P; Beddington, RS; Rigby, PW; (1998) Isolation of developmentally regulated genes by differential display screening of cDNA libraries. Nucleic Acids Res , 26 (19) pp. 4538-4539. 10.1093/nar/26.19.4538.

H

Harrison, C; Chitolie, A; Carr, P; Dave, M; Mackie, I; Machin, S; (1998) Evaluation of risk factors for thrombosis in patients with essential thrombocythaemia. BRIT J HAEMATOL , 101 105 - 105.

Harrison, C; Donohoe, S; Chitolie, A; Carr, P; Mackie, I; Machin, S; (1998) Evaluation of risk factors for thrombosis in patients with essential thrombocythaemia. BRIT J HAEMATOL , 102 (1) 368 - 368.

Harrison, CN; Gale, RE; Linch, DC; (1998) Quantification of X-chromosome inactivation patterns using RT-PCR of the polymorphic iduronate-2-sulphatase gene and correlation of the results obtained with DNA-based techniques. LEUKEMIA , 12 (11) 1834 - 1839.

Harrison, CN; Gale, RE; Wiestner, AC; Skoda, RC; Linch, DC; (1998) The activating splice mutation in intron 3 of the thrombopoietin gene is not found in patients with non-familial essential thrombocythaemia. BRIT J HAEMATOL , 102 (5) 1341 - 1343.

Harrison, CN; Hudson, GV; Devereux, S; Linch, DC; (1998) Outcome of secondary myeloid malignancy in Hodgkin's disease: the BNLI experience. EUR J HAEMATOL , 61 (2) 109 - 112.

Harrison, CN; Linch, DC; Machin, SJ; (1998) Desirability and problems of early diagnosis of essential thrombocythaemia. LANCET , 351 (9106) 846 - 847.

Harrison, CN; Mire-Sluis, A; Abernethy, H; Gale, RE; Machin, SJ; Linch, DC; (1998) Markedly reduced expression of the thrombopoietin receptor MPL in platelets from patients with monoclonal and polyclonal essential thrombocythaemia. BRIT J HAEMATOL , 101 28 - 28.

Harrison, P; Robinson, M; Pasi, J; Savidge, G; Mackie, I; Machin, S; (1998) The PFA-100 (TM) system: A unique high shear in vitro test of platelet function. BRIT J HAEMATOL , 101 90 - 90.

Harvey, RC; Cook, RW; Clark, TJ; Linch, DC; (1998) Application of TMA and HPA to the identification of fusion transcripts in archived RNA from patients with leukemia. BLOOD , 92 (10) 201B - 201B.

Hughes, DA; Gordon, S; (1998) Expression and function of the type 3 complement receptor in tissues of the developing mouse. JOURNAL OF IMMUNOLOGY , 160 (9) pp. 4543-4552.

Hunt, DM; Holmes, Z; Pickering, W; Cohen, H; (1998) Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease (78-A: 3-13, Jan. 1996). The Journal of bone and joint surgery. American volume , 80 pp. 604-606.

I

Inanc, M; Donohoe, S; Ravirajan, CT; Radway-Bright, EL; Mackie, I; Machin, S; Isenberg, DA; (1998) Anti-beta 2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome. BRIT J RHEUMATOL , 37 (10) 1089 - 1094.

Inanç, M; Donohoe, S; Ravirajan, CT; Radway-Bright, EL; Mackie, I; Machin, S; Isenberg, DA; (1998) Anti-β2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome. British Journal of Rheumatology , 37 (10) pp. 1089-1094.

Ings, SJ; Watts, MJ; Linch, DC; (1998) The post G-CSF white cell count is predictive for subsequent apheresis progenitor yields. BRIT J HAEMATOL , 101 95 - 95.

J

Joseph, JE; Donohoe, S; Harrison, P; Mackie, IJ; Machin, SJ; (1998) Platelet activation and turnover in the primary antiphospholipid syndrome. LUPUS , 7 (5) 333 - 340.

Joseph, JE; Donohoe, S; Harrison, P; Mackie, IJ; Machin, SJ; (1998) Platelet activation and turnover in the primary antiphospholipid syndrome. Lupus , 7 (5) pp. 333-340.

Joseph, JE; Harrison, P; Mackie, IJ; Machin, SJ; (1998) Platelet activation and soluble P-selectin levels in the primary antiphospholipid syndrome (PAPS). BRIT J HAEMATOL , 102 (1) 250 - 250.

Joseph, JE; Harrison, P; Mackie, IJ; Machin, SJ; (1998) Platelet activation markers and the primary antiphospholipid syndrome (PAPS). LUPUS , 7 S48 - S51.

Joseph, JE; Harrison, P; Mackie, IJ; Machin, SJ; (1998) Platelet activation markers and the primary antiphospholipid syndrome (PAPS). Lupus , 7 (2) S48-S51.

K

Kasprzyk, A.; (1998) Investigation of clonality and minimal residual disease in haematological malignancy using fluorescent in situ hybridization. Doctoral thesis , University of London. Green open access
file

Khwaja, A; Hassan, R; Tatton, EL; Watts, TM; Linch, DC; (1998) GM-CSF and G-CSF inhibition of apoptosis is mediated by different signal transduction pathways dependent on the stage of myeloid differentiation. BLOOD , 92 (10) 159B - 159B.

Khwaja, A; Lehmann, K; Marte, BM; Downward, J; (1998) Phosphoinositide 3-kinase induces scattering and tubulogenesis in epithelial cells through a novel pathway. J BIOL CHEM , 273 (30) 18793 - 18801. Gold open access

Khwaja, A; Tatton, EL; (1998) Caspase-mediated proteolysis and activation of PKC delta plays a central role in neutrophil apoptosis. BLOOD , 92 (10) 15A - 15A.

Khwaja, A; Tatton, EL; (1998) Resistance to the cytotoxic effects of TNF alpha can be overcome by inhibition of a FADD/Caspase-dependent signalling pathway. BLOOD , 92 (10) 371A - 371A.

Koh, MBC; Lowdell, MW; Prentice, HG; (1998) The differential effects of cytokines on the expression of major histocompatibility antigens and adhesion molecules on lymphocytes. BLOOD , 92 (10) 60B - 60B.

L

Langabeer, SE; Allford, S; Grimwade, D; Chatters, SJ; Walker, H; Oliver, FJ; Rogers, JR; ... Linch, DC; + view all (1998) Two cases of t(15;17) not associated with APL and the value of molecular screening for PML/RAR alpha in AML. BRIT J HAEMATOL , 101 31 - 31.

Langabeer, SE; Grimwade, D; Walker, H; Rogers, JR; Burnett, AK; Goldstone, AH; Linch, DC; (1998) A study to determine whether trisomy 8, deleted 9q and trisomy 22 are markers of cryptic rearrangements of PML/RARalpha, AML1/ETO and CBFB/MYH11 respectively in acute myeloid leukaemia. MRC Adult Leukaemia Working Party. Medical Research Council. Br J Haematol , 101 (2) pp. 338-340.

Langabeer, SE; Grimwade, D; Walker, H; Rogers, JR; Burnett, AK; Goldstone, AH; Linch, DC; (1998) A study to determine whether trisomy 8, deleted 9q and trisomy 22 are markers of cryptic rearrangements of PML/RAR alpha, AML1/ETO and CBFB/MYH11 respectively in acute myeloid leukaemia. BRIT J HAEMATOL , 101 (2) 338 - 340.

Langabeer, SE; Linch, DC; (1998) IL-1 receptor antagonist gene polymorphism in patients with secondary acute myeloid leukaemia. CYTOKINES CELL MOL T , 4 (1) 7 - 9.

Lawrie, AS; Kitchen, S; Purdy, G; Mackie, IJ; Preston, FE; Machin, SJ; (1998) Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies. Clinical and Laboratory Haematology , 20 (3) pp. 179-186. 10.1046/j.1365-2257.1998.00122.x.

Lawrie, AS; Kitchen, S; Purdy, G; Mackie, IJ; Preston, FE; Machin, SJ; (1998) Assessment of actin FS and actin FSL sensitivity to specific clotting factor deficiencies. CLIN LAB HAEMATOL , 20 (3) 179 - 186.

Lawrie, AS; Mackie, IJ; Purdy, G; Machin, SJ; (1998) The influence of analyser type on sensitivity and specificity of lupus anticoagulant testing reagents. BRIT J HAEMATOL , 102 (1) 259 - 259.

Lawrie, AS; McDonald, SJ; Purdy, G; Mackie, IJ; Machin, SJ; (1998) Prothrombin time derived fibrinogen determination on Sysmex CA-6000(TM). Journal of Clinical Pathology , 51 (6) pp. 462-466. 10.1136/jcp.51.6.462.

Lawrie, AS; McDonald, SJ; Purdy, G; Mackie, IJ; Machin, SJ; (1998) Prothrombin time derived fibrinogen determination on Sysmex CA6000 (TM). J CLIN PATHOL , 51 (6) 462 - 466.

Lawrie, AS; Purdy, G; Mackie, IJ; Machin, SJ; (1998) Monitoring oral anticoagulant therapy in patients with lupus anticoagulants. BRIT J HAEMATOL , 101 (2) 391 - 392.

Lawrie, AS; Purdy, G; Mackie, IJ; Machin, SJ; (1998) The sensitivity and specificity of reagents for lupus anticoagulant testing vary between photo-optical and mechanical coagulometers. BRIT J HAEMATOL , 101 57 - 57.

Liesner, R; Mackie, I; Cookson, J; McDonald, S; Chitolie, A; Donohoe, S; Evans, J; ... Machin, S; + view all (1998) Prothrombotic changes in children with sickle cell disease: Relationships to cerebrovascular disease and transfusion. British Journal of Haematology , 103 (4) pp. 1037-1044. 10.1046/j.1365-2141.1998.01121.x.

Liesner, R; Mackie, I; Cookson, J; McDonald, S; Chitolie, A; Donohoe, S; Evans, J; ... Machin, S; + view all (1998) Prothrombotic changes in children with sickle cell disease: relationships to cerebrovascular disease and transfusion. BRIT J HAEMATOL , 103 (4) 1037 - 1044.

Linch, DC; (1998) Non-Hodgkin's Lymphoma: Histologically Aggressive. In: Whittaker, JA and Holmes, JA, (eds.) Leukaemia and related disorders. (pp. 376-391). Blackwell Science Ltd: Oxford, UK.

Linch, DC; Milligan, DW; Winfield, DA; Kelsey, SM; Johnson, SA; Littlewood, TJ; Smith, GM; ... Hudson, GV; + view all (1998) G-CSF after PBSC transplantation. BRIT J HAEMATOL , 101 (3) 595 - 596.

Linch, DC; Smith, P; Gregory, WM; Hoskin, P; Cunningham, D; Hancock, BW; Rhodes, E; (1998) Preliminary results of a randomised BNLI trial of chop vs CIOP (Idarubicin 10 mg/g(2) replacing hydroxydaunorubicin 50 mg/m(2)) in good prognosis younger patients with histologically aggressive non-Hodgkin's lymphoma (NHL). BLOOD , 92 (10) 620A - 620A.

Little, AM; Marsh, SG; Madrigal, JA; (1998) Current methodologies of human leukocyte antigen typing utilized for bone marrow donor selection. Curr Opin Hematol , 5 (6) pp. 419-428.

Lowdell, MW; Craston, R; Ray, N; Koh, M; Galatowicz, G; Prentice, HG; (1998) The effect of T cell depletion with Campath-1M on immune reconstitution after chemotherapy and allogeneic bone marrow transplant as treatment for leukaemia. BONE MARROW TRANSPL , 21 (7) 679 - 686.

M

MACHIN, S; (1998) ELISA using monoclonal and polyclonal antibodies.

Mackie, IJ; Gardiner, C; Machin, SJ; Greaves, M; Malia, R; Jones, DW; others, ; (1998) Medical Devices Agency Evaluation Report. Three lupus anticoagulant kits. : MDA/98/43. Norwich: HMSO.

Mackie, IJ; Lawrie, AS; Kitchen, S; Howarth, D; Rigsby, P; (1998) The BCSH/MDA study of commercial fibrinogen reference preparations. BRIT J HAEMATOL , 101 57 - 57.

Mackie, IJ; Lawrie, AS; Purdy, G; Kitchen, S; Howarth, D; Martin, J; Rigsby, P; (1998) The BCSH/MDA study of commercial fibrinogen reference preparations. BRIT J HAEMATOL , 102 (1) 260 - 261.

Madge, S; Phillips, AN; Griffioen, A; Olaitan, A; Johnson, MA; (1998) Demographic, clinical and social factors associated with human immunodeficiency virus infection and other sexually transmitted diseases in a cohort of women from the United Kingdom and Ireland. MRC Collaborative Study of women with HIV. Int J Epidemiol , 27 (6) pp. 1068-1071. 10.1093/ije/27.6.1068.

Madge, S; Phillips, AN; Griffioen, A; Olaitan, A; Johnson, MA; MRC Collaborative Study Women HIV, ; (1998) Demographic, clinical and social factors associated with human immunodeficiency virus infection and other sexually transmitted diseases in a cohort of women from the United Kingdom and Ireland. INT J EPIDEMIOL , 27 (6) 1068 - 1071.

Marks, AJ; Perry, AR; Kottaridis, PD; Peniket, AJ; Hale, G; Waldmann, H; Patterson, K; ... Mackinnon, S; + view all (1998) Treatment with CAMPATH 1G leads to emergence of an occult PNH clone. BONE MARROW TRANSPL , 21 S98 - S98.

Marsh, SG; (1998) HLA class II region sequences, 1998. Tissue Antigens , 51 (4 Pt 2) pp. 467-507.

Marsh, SG; (1998) Nomenclature for factors of the HLA system, update April 1998. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 52 (3) 300-.

Marsh, SG; (1998) Nomenclature for factors of the HLA system, update February 1998. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 51 (5) pp. 584-585.

Marsh, SG; (1998) Nomenclature for factors of the HLA system, update January 1998. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 51 (5) pp. 582-583.

Marsh, SG; (1998) Nomenclature for factors of the HLA system, update January 1998. WHO Nomenclature Committee for factors of the HLA system. Hum Immunol , 59 (4) pp. 256-257.

Marsh, SG; (1998) Nomenclature for factors of the HLA system, update July 1998. WHO Nomenclature Committee for Factors of the HLA System. Hum Immunol , 59 (11) pp. 748-749.

Marsh, SG; (1998) Nomenclature for factors of the HLA system, update July 1998. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 52 (4) pp. 405-406.

Marsh, SG; (1998) Nomenclature for factors of the HLA system, update July/August 1997. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 51 (2) pp. 213-214.

Marsh, SG; (1998) Nomenclature for factors of the HLA system, update March 1998. Hum Immunol , 59 (7) pp. 456-458.

Marsh, SG; (1998) Nomenclature for factors of the HLA system, update November/December 1997. WHO Nomenclature Committee for Factors of the HLA System. Hum Immunol , 59 (2) 135-.

Marsh, SG; (1998) Nomenclature for factors of the HLA system, update September 1998. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 52 (6) pp. 592-593.

Marsh, SG; (1998) Nomenclature for factors of the HLA system, update September/October 1997. WHO Nomenclature Committee for Factors of the HLA System. Hum Immunol , 59 (2) pp. 133-134.

Marsh, SGE; (1998) HLA class II region sequences, 1998. TISSUE ANTIGENS , 51 (4) pp. 467-507.

Marsh, SGE; (1998) Nomenclature for factors of the HLA system, update April 1998. TISSUE ANTIGENS , 52 (3) p. 300. 10.1111/j.1399-0039.1998.tb03048.x.

Marsh, SGE; (1998) Nomenclature for factors of the HLA system, update April 1998. HUMAN IMMUNOLOGY , 59 (10) p. 677.

Marsh, SGE; (1998) Nomenclature for factors of the HLA system, update April 1998. EUROPEAN JOURNAL OF IMMUNOGENETICS , 25 (5) p. 379. 10.1046/j.1365-2370.1998.00130.x.

Marsh, SGE; (1998) Nomenclature for factors of the HLA system, update August 1998. EUROPEAN JOURNAL OF IMMUNOGENETICS , 25 (6) p. 425.

Marsh, SGE; (1998) Nomenclature for factors of the HLA system, update February 1998. TISSUE ANTIGENS , 51 (5) pp. 584-585. 10.1111/j.1399-0039.1998.tb02999.x.

Marsh, SGE; (1998) Nomenclature for factors of the HLA system, update February 1998. HUMAN IMMUNOLOGY , 59 (5) p. 323.

Marsh, SGE; (1998) Nomenclature for factors of the HLA system, update February 1998. EUROPEAN JOURNAL OF IMMUNOGENETICS , 25 (4) p. 323. 10.1046/j.1365-2370.1998.00106.x.

Marsh, SGE; (1998) Nomenclature for factors of the HLA system, update January 1998. TISSUE ANTIGENS , 51 (5) pp. 582-583. 10.1111/j.1399-0039.1998.tb02998.x.

Marsh, SGE; (1998) Nomenclature for factors of the HLA system, update January 1998. HUMAN IMMUNOLOGY , 59 (4) pp. 256-257.

Marsh, SGE; (1998) Nomenclature for factors of the HLA system, update January 1998. EUROPEAN JOURNAL OF IMMUNOGENETICS , 25 (4) p. 321. 10.1046/j.1365-2370.1998.00103.x.

Marsh, SGE; (1998) Nomenclature for factors of the HLA system, update July 1998. TISSUE ANTIGENS , 52 (4) pp. 405-406. 10.1111/j.1399-0039.1998.tb03065.x.

Marsh, SGE; (1998) Nomenclature for factors of the HLA system, update July 1998. HUMAN IMMUNOLOGY , 59 (11) pp. 748-749.

Marsh, SGE; (1998) Nomenclature for factors of the HLA system, update July 1998. EUROPEAN JOURNAL OF IMMUNOGENETICS , 25 (5) p. 383. 10.1046/j.1365-2370.1998.00137.x.

Marsh, SGE; (1998) Nomenclature for factors of the HLA system, update July/August 1997. TISSUE ANTIGENS , 51 (2) pp. 213-214.

Marsh, SGE; (1998) Nomenclature for factors of the HLA system, update March 1998. TISSUE ANTIGENS , 51 (6) pp. 681-683. 10.1111/j.1399-0039.1998.tb03016.x.

Marsh, SGE; (1998) Nomenclature for factors of the HLA system, update March 1998. EUROPEAN JOURNAL OF IMMUNOGENETICS , 25 (4) pp. 325-326. 10.1046/j.1365-2370.1998.00118.x.

Marsh, SGE; (1998) Nomenclature for factors of the HLA system, update May/June 1998. HUMAN IMMUNOLOGY , 59 (10) p. 678.

Marsh, SGE; (1998) Nomenclature for factors of the HLA system, update May/June 1998. TISSUE ANTIGENS , 52 (3) p. 301. 10.1111/j.1399-0039.1998.tb03049.x.

Marsh, SGE; (1998) Nomenclature for factors of the HLA system, update May/June 1998. EUROPEAN JOURNAL OF IMMUNOGENETICS , 25 (5) p. 381. 10.1046/j.1365-2370.1998.00131.x.

Marsh, SGE; (1998) Nomenclature for factors of the HLA system, update November/December 1997. TISSUE ANTIGENS , 51 (3) p. 317.

Marsh, SGE; (1998) Nomenclature for factors of the HLA system, update November/December 1997. EUROPEAN JOURNAL OF IMMUNOGENETICS , 25 (1) p. 43. 10.1046/j.1365-2370.1998.00096.x.

Marsh, SGE; (1998) Nomenclature for factors of the HLA system, update September 1998. EUROPEAN JOURNAL OF IMMUNOGENETICS , 25 (6) p. 427.

Marsh, SGE; (1998) Nomenclature for factors of the HLA system, update September/October 1997. HUMAN IMMUNOLOGY , 59 (2) pp. 133-134.

Marsh, SGE; (1998) Nomenclature for factors of the HLA system, update September/October 1997. TISSUE ANTIGENS , 51 (3) pp. 315-316.

Martinez-Arends, A; Layrisse, Z; Arguello, R; Herrera, F; Montagnani, S; Matos, M; Ross, J; ... Madrigal, JA; + view all (1998) Characterization of the HLA class I genotypes of a venezuelan Amerindian group by molecular methods. TISSUE ANTIGENS , 52 (1) pp. 51-56. 10.1111/j.1399-0039.1998.tb03023.x.

McDonald, SJ; Lawrie, AS; Purdy, G; Mackie, IJ; Porter, JB; Machin, SJ; (1998) Endothelial damage in sickle cell disease. BRIT J HAEMATOL , 102 (1) 357 - 357.

McGuckin, CP; Pearce, D; Pizzey, A; Gordon-Smith, EC; Uhr, M; Pettengell, R; (1998) Identification of emerging CD34 progenitor subsets. BLOOD , 92 (10) 146B-147B.

Mehta, AB; McIntyre, N; (1998) Haematological disorders in liver disease. Trends in Experimental and Clinical Medicine , 8 pp. 8-25.

Mehta, AB; Shah, ; S, ; Secker-Walker, ; LM, ; Bain, ; B, ; ... M, ; + view all (1998) Trisomy 13 and AML: Characteristic blast cell morphology. British Journal of Haematology , 101 pp. 749-752.

Mollapour, E; Khwaja, A; Linch, DC; Roberts, PJ; (1998) Activation and priming of neutrophil NADPH oxidase and phospholipase A(2) are dissociated by inhibition of ERK2 and p38 kinases. BLOOD , 92 (10) 533A - 533A.

Mollapour, E; Porter, JB; Kaczmarski, R; Linch, DC; Roberts, PJ; (1998) Raised neutrophil phospholipase A(2) activity and defective priming of NADPH oxidase and phospholipase A(2) in sickle cell disease. BLOOD , 91 (9) 3423 - 3429.

Morgan, CL; Ruprai, AK; Solache, A; Lowdell, M; Price, CP; Cohen, SBA; Parham, P; ... Newman, DJ; + view all (1998) The influence of exogenous peptide on beta(2)-microglobulin exchange in the HLA complex: analysis in real-time. IMMUNOGENETICS , 48 (2) pp. 98-107. 10.1007/s002510050409.

Mundee, Y; Bigelow, N; Davis, BH; Porter, JB; (1998) Evaluation of a new flow cytometric method for measurement of foetal haemoglobin containing reticulocytes (F-retics). BRIT J HAEMATOL , 101 53 - 53.

Mundee, Y; Bigelow, NC; Davis, BH; Porter, JB; (1998) Adhesion molecule expression on F-cells in sickle cell patients and in control subjects. BLOOD , 92 (10) 329A - 329A.

Murphy, MF; Murphy, W; Wheatley, K; Goldstone, AH; (1998) Survey of the use of platelet transfusions in centres participating in MRC leukaemia trials. British Journal of Haematology , 102 (3) pp. 875-876.

N

Nicoll, A; Stephenson, J; Griffioen, A; Cliffe, S; Rogers, P; Boisson, E; (1998) The relationship of HIV prevalence in pregnant women to that in women of reproductive age: a validated method for adjustment. AIDS , 12 (14) pp. 1861-1867. 10.1097/00002030-199814000-00018.

Noble, KE; Yong, K; Khwaja, A; (1998) Neutrophil transendothelial migration is regulated by the calcium dependent protease calpain. BLOOD , 92 (10) 535A - 535A.

Norfolk, DR; Ancliffe, PJ; Contreras, M; Hunt, BJ; Machin, SJ; Murphy, WG; Williamson, LM; (1998) Consensus Conference on Platelet Transfusion, Royal College of Physicians of Edinburgh, 27-28 November 1997 - Synopsis of background papers. BRIT J HAEMATOL , 101 (4) 609 - +.

O

Orrell, RW; Jurkat-Rott, K; Lehmann-Horn, F; Lane, RJM; (1998) Familial cramp due to potassium-aggravated myotonia. J NEUROL NEUROSUR PS , 65 (4) 569 - 572.

P

Papadopoulos, EB; Carabasi, MH; Castro-Malaspina, H; Childs, BH; Mackinnon, S; Boulad, F; Gillio, AP; ... Young, JW; + view all (1998) T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease. Blood , 91 (3) pp. 1083-1090.

Pawson, R; Mehta, A; (1998) Review Article: The diagnosis and treatment of haematinic deficiency in gastrointestinal disease. Alimentary Pharmacology and Therapeutics , 12 pp. 687-698.

Peggs, K; Kottaridis, P; Goldstone, AH; Littlewood, T; Mackinnon, S; (1998) Impaired T cell reconstitution following high dose therapy supported with CD34+ selected or unselected peripheral blood stem cells in patients with multiple myeloma. In: BLOOD. (pp. 337B - 337B). W B SAUNDERS CO

Peniket, AJ; Linch, DC; (1998) Hodgkin's disease. In: Barrett, J and Treleaven, J, (eds.) Volume 1 The Clinical Practice of Stem-Cell Transplantation. (pp. 129-149). Isis Medical Media Ltd: Oxford, UK.

Peniket, AJ; Perry, AR; Williams, CD; MacMillan, A; Watts, MJ; Isaacson, PG; Goldstone, AH; (1998) A case of EBV-associated lymphoproliferative disease following high-dose therapy and CD34-purified autologous peripheral blood progenitor cell transplantation. BONE MARROW TRANSPL , 22 (3) 307 - 309.

Perry, AR; Goldstone, AH; (1998) High-dose therapy for diffuse large-cell lymphoma in first remission. Annals of Oncology , 9 (1) S9-S14.

Perry, AR; Peniket, AJ; Watts, MJ; Ings, SJ; Goldstone, AH; Mackinnon, S; (1998) A successful re-induction/immunotherapy regimen for acute leukaemia relapsing after sibling allograft. BONE MARROW TRANSPL , 21 S69 - S69.

Perry, AR; Watts, MJ; Peniket, AJ; Goldstone, AH; Linch, DC; (1998) Progenitor cell yields are frequently poor in patients with histologically indolent lymphomas especially when mobilized within 6 months of previous chemotherapy. BONE MARROW TRANSPL , 21 (12) 1201 - 1205.

Pittoni, V; Ravirafan, CT; Donohoe, S; Machin, SJ; Mackie, IJ; Lvdvard, PM; Isenberg, DA; (1998) Human monoclonal antiphospholipid antibodies bind to membrane phospholipid and a cryptic epitope of beta 2-glycoprotein 1 on apoptotic cells. ARTHRITIS RHEUM , 41 (9) S166 - S166.

Pollard, Y; Watts, MJ; Grant, D; Chavda, N; Linch, DC; (1998) An adequate CD34+ cell apheresis yield is unlikely with low Sysmex SE-9500 haemopoietic progenitor cell (HPC) blood counts. BRIT J HAEMATOL , 102 (1) 76 - 77.

Pollard, Y; Watts, MJ; Grant, D; Chavda, N; Linch, DC; Machin, SJ; (1998) Use of the haemopoietic progenitor cell (HPC) count of the Sysmex SE-9500 to improve timing for peripheral blood stem cell (PBSC) collection. BLOOD , 92 (10) 305B - 305B.

Porter, JB; Alberti, D; Hassan, I; Racine, A; Davis, B; Voi, V; Piga, A; (1998) Phase I, single dose trial on depot desferrioxamine (CGH 749B) in transfusion-dependent beta-thalassemic patients. BRIT J HAEMATOL , 102 (1) 280 - 280.

Porter, JB; Faherty, A; Stallibrass, L; Brookman, L; Hassan, I; Howes, C; (1998) A trial to investigate the relationship between DFO pharmacokinetics and metabolism and DFO-related toxicity. COOLEYS ANEMIA , 850 483 - 487.

Porter, JB; Srichairatanakool, S; Nathan, DG; Schinkel, H; Gee, B; Olivieri, NF; (1998) Relative efficacy of subcutaneous infusions and bolus injections of deferoxamine in the removal of non-transferrin-bound iron (NTBI). BLOOD , 92 (10) 668A - 668A.

Porter, JB; Wier, DT; Davis, B; Alexander, E; McCombie, RR; Walker, SM; Osborne, S; (1998) Iron balance and chelation efficiency following single dose depot desferrioxamine. BLOOD , 92 (10) 325A - 325A.

Pouwels, K; Gale, RE; Langabeer, S; Linch, DC; (1998) A G-CSF receptor with a 3bp deletion in the cytoplasmic region due to alternative splicing. BRIT J HAEMATOL , 102 (1) 164 - 164.

R

Ramon, DS; Arguello, JR; Cox, ST; McWhinnie, A; Little, AM; Marsh, SGE; Madrigal, JA; (1998) Application of RSCA for the typing of HLA-DPB1. Human Immunology , 59 pp. 51-56.

Ramon, DS; Arguello, JR; Cox, ST; McWhinnie, A; Little, AM; Marsh, SGE; Madrigal, JA; (1998) Application of RSCA for the typing of HLA-DPB1. HUMAN IMMUNOLOGY , 59 (11) pp. 734-747. 10.1016/S0198-8859(98)00079-2.

Rees, DC; Porter, JB; Clegg, JB; Weatherall, DJ; (1998) Insights into the causes of increased RBF production in HbE/beta thalassemia - The effects of blood transfusion. BLOOD , 92 (10) 697A - 697A.

Rege, KP; Bevan, DH; Chitolie, A; Shannon, MS; (1998) Risk factors and thrombosis after airline flight. BLOOD , 92 (10) 125B - 125B.

Rendahl, KG; Leff, SE; Otten, GR; Spratt, SK; Bohl, D; Van Roey, M; Donahue, BA; ... Snyder, RO; + view all (1998) Regulation of gene expression in vivo following transduction by two separate rAAV vectors. Nat Biotechnol , 16 (8) pp. 757-761. 10.1038/nbt0898-757.

Riordan, FA; Bravery, CA; Mengubas, K; Ray, N; Borthwick, NJ; Akbar, AN; Hart, SM; ... Wickremasinghe, RG; + view all (1998) Herbimycin A accelerates the induction of apoptosis following etoposide treatment or gamma-irradiation of bcr/abl-positive leukaemia cells. ONCOGENE , 16 (12) 1533 - 1542.

Riordan, FA; Foroni, L; Hoffbrand, AV; Mehta, AB; Wickremasinghe, RG; (1998) Okadaic acid-induced apoptosis of HL60 leukemia cells is preceded by destabilization of bcl-2 mRNA and downregulation of bcl-2 protein. FEBS LETT , 435 (2-3) 195 - 198.

Riordan, FA; Wickremasinghe, RG; (1998) Signal Transduction by the Philadelphia Chromosome-encoded BCR/ABL Oncoproteins: Therapeutic Implications for Chronic Myeloid Leukemia and Philadelphia-positive Acute Lymphoblastic Leukemia. Hematology , 3 (5) pp. 387-396. 10.1080/10245332.1998.11746413.

Roberts, PJ; Mollapour, E; Watts, MJ; Linch, DC; (1998) Activation of phospholipase A(2) during differentiation of human haemopoietic progenitor cells. BIOCHEMICAL SOCIETY TRANSACTIONS , 26 (3) S233 - S233.

Roberts, PJ; Mollapour, E; Watts, MJ; Linch, DC; (1998) Stem cell factor primes phospholipase A(2) activity in primitive myeloid cells. BLOOD , 92 (10) 364A - 364A.

Robinson, LG; Austin, SJ; Owen-Jones, CE; Langabeer, SE; Linch, DC; Mills, KI; Burnett, AK; (1998) Multiplex PCR for the detection of prognostically important gene rearrangements in acute myeloid leukaemia. BRIT J HAEMATOL , 101 21 - 21.

Robinson, MS; Harrison, C; Mackie, IJ; Machin, SJ; Harrison, P; (1998) Reticulated platelets in primary and reactive thrombocytosis. British Journal of Haematology , 101 (2) pp. 388-389.

Robinson, MSC; Harrison, C; Mackie, IJ; Machin, SJ; Harrison, P; (1998) Reticulated platelets in primary and reactive thrombocytosis. BRIT J HAEMATOL , 101 (2) 388 - 389.

Robinson, MSC; Horton, A; Wyatt, J; Mackie, IJ; Machin, SJ; Harrison, P; (1998) Potential of coriphosphine O for the measurement of reticulated platelets. BRIT J HAEMATOL , 102 (1) 366 - 366.

Robinson, MSC; MacKie, IJ; Knam, K; Liesner, R; Goodall, AH; Savmce, GF; MacHin, SJ; (1998) Flow cytometric analysis of reticulated platelets: Evidence for a large proportion of non-specific labelling of dense granules by fluorescent dyes. British Journal of Haematology , 100 (2) pp. 351-357. 10.1046/j.1365-2141.1998.00563.x.

Robinson, MSC; Mackie, IJ; Khair, K; Liesner, R; Goodall, AH; Savidge, GF; Machin, SJ; (1998) Flow cytometric analysis of reticulated platelets: evidence for a large proportion of non-specific labelling of dense granules by fluorescent dyes. BRIT J HAEMATOL , 100 (2) 351 - 357.

S

Sabin, CA; Devereux, H; Kinson, Z; Griffioen, A; Brown, D; Dusheiko, G; Lee, CA; (1998) Effect of coinfection with hepatitis G virus on HIV disease progression in hemophilic men. J ACQ IMMUN DEF SYND , 19 (5) 546 - 547.

Saharay, M; Shields, DA; Georgiannos, SN; Porter, JB; Scurr, JH; Smith, PDC; (1998) Endothelial activation in patients with chronic disease. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY , 15 (4) 342 - 349.

Scott, CL; Hughes, DA; Cary, D; Nicola, NA; Begley, CG; Robb, L; (1998) Functional analysis of mature hematopoietic cells from mice lacking the beta c chain of the granulocyte-macrophage colony-stimulating factor receptor. BLOOD , 92 (11) pp. 4119-4127.

Secker-Walker, LM; Bain, BJ; Moorman, AV; Mehta, ABOBOEQW; (1998) Secondary acute leukaemia and myelodysplastic syndrome with 11q23 abnormalities. Leukaemia , 12 pp. 840-844.

Shoab, SS; Porter, J; Schurr, JH; Coleridge-Smith, PD; (1998) Effect of oral micronised flavonoid fraction on endothelial activation markers in patients with chronic venous disease. J VASC RES , 35 (5) 382 - 382.

Shoab, SS; Porter, J; Scurr, JH; Coleridge Smith, DP; (1998) Effect of oral micronised purified flavonoid fraction treatment on leucocyte adhesion molecule expression in patients with chronic venous disease. J VASC RES , 35 (5) 382 - 382.

Singer, IO; Franklin, IM; Clark, RE; Chalmers, EA; Kelsey, SM; Newland, AC; Sproul, AM; ... Tansey, PJ; + view all (1998) Autologous transplantation in chronic myeloid leukaemia using peripheral blood stem cells. British Journal of Haematology , 102 (5) pp. 1359-1362.

Somers, LJ; Shaw, B; Lyn, BE; McMillan, AM; Mahendra, P; (1998) Meningeal myeloma in the absence of systemic disease, and as the initial feature of disease progression. Clin Lab Haematol , 20 (3) pp. 189-190.

T

Taniguchi, T; Kakkar, AK; Tuddenham, EGD; Williamson, RCN; Lemoine, NR; (1998) Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer. CANCER RESEARCH , 58 (19) pp. 4461-4467.

Taylor, F; Ebrahim, S; Cohen, H; (1998) In occlusive vascular disease, long-term anticoagulantion is no more beneficial than antiplatelet treatment. In: (Proceedings) British society for haematology annual scientific meeting.

Thomas, NSB; Pizzey, AR; Tiwari, SJ; Williams, CD; Yang, JW; (1998) p130, p107, and pRb are differentially regulated in proliferating cells and during cell cycle arrest by alpha-interferon. JOURNAL OF BIOLOGICAL CHEMISTRY , 273 (37) pp. 23659-23667. 10.1074/jbc.273.37.23659. Gold open access

V

Vincent, T; Rai, R; Regan, L; Cohen, H; (1998) Increased thrombin generation in women with recurrent miscarriage. Lancet , 352 (9122) 116-. 10.1016/S0140-6736(98)85022-8.

Virchis, AE; Ganeshaguru, K; Fletcher, L; Reese, SF; Yap, A; Champain, K; Hart, SM; ... Mehta, AB; + view all (1998) Updated results of an exploratory-phase II study on a protein kinase C inhibitor in low grade lymphoproliferative disorders. BLOOD , 92 (10) 284B - 284B.

Virchis, AE; Ganeshaguru, K; Prentice, HG; Yong, KL; Man, A; Csermak, K; Meyer, T; ... Mehta, AB; + view all (1998) Results of an exploratory phase ii study on a protein kinase C inhibitor in low grade lymphoproliferative disorders. BRIT J HAEMATOL , 102 (1) 192 - 192.

Virchis, AE; Jan-Mohammed, R; Kaczmarski, KS; Barker, FG; Mehta, AB; (1998) Primary splenic hairy cell leukaemia variant presenting as immune thrombocytopenic purpura. European Journal of Haematology , 61 2988-.

Vulliamy, TJ; Kaeda, JS; Ati-Chafa, D; Mangerini, R; Roper, D; Barbot, J; Mehta, AB; ... Luzzatto, LMPJ; + view all (1998) Clinical and haematological consequences of recurrent G6PD mutations and a single new mutation causing chronic non-spherocytic haemolytic anaemia. British Journal of Haematology , 101 pp. 670-675.

W

Watts, MJ; Addison, I; Ings, SJ; Long, SG; Hartley, S; Warrington, S; Boyce, M; (1998) Optimal timing for collection of PBPC after glycosylated G-CSF administration. BONE MARROW TRANSPL , 21 (4) 365 - 368.

Watts, MJ; Sullivan, AM; Ings, SJ; Barlow, M; Devereux, S; Goldstone, AH; Linch, DC; (1998) Storage of PBSC at -80 degrees C. BONE MARROW TRANSPL , 21 (1) 111 - 112.

Watts, MJ; Sullivan, AM; Leverett, D; Peniket, AJ; Perry, AR; Williams, CD; Devereux, S; ... Linch, DC; + view all (1998) Back-up bone marrow is frequently ineffective in patients with poor peripheral-blood stem-cell mobilization. J CLIN ONCOL , 16 (4) 1554 - 1560.

Wheadon, H; Roberts, PJ; Linch, DC; (1998) Differentiation-linked changes in granulocyte-macrophage colony-stimulating factor receptor mediated signalling in the HL-60 promyelocytic cell line. BRIT J HAEMATOL , 101 (1) 82 - 89.

Wickramasinghe, SN; Vora, AJ; Will, A; Winfield, DA; Hughes, RG; Sekhar, M; Loftus, G; (1998) Transfusion-dependent congenital dyserythropoietic anaemia with non-specific dysplastic changes in erythroblasts. EUROPEAN JOURNAL OF HAEMATOLOGY , 60 (2) pp. 140-142.

Wickremasinghe, RG; Hoffbrand, AV; (1998) The molecular basis of leukaemia and lymphoma. In: Hoffbrand, AV and Lewis, SM and Tuddenham, EGD, (eds.) Postgraduate haematology. (pp. 354-372). Butterworth Heinemann: Oxford.

Wickremasinghe, RG; Mengubas, K; Riordan, FA; Lewin, J; Mehta, AB; Prentice, HG; Hoffbrand, AV; (1998) A synthetic ceramide analog induces non-apoptotic killing of normal and malignant human B lymphocytes. BLOOD , 92 (10) 197B - 197B.

Wickremasinghe, RG; Riordan, FA; Hoffbrand, AV; Mehta, AB; Foroni, L; (1998) Destabilization of spliced and unspliced bcl-2 transcripts precedes okadaic acid-induced apoptosis in HL60 leukemia cells. BLOOD , 92 (10) 167B - 167B.

Wiener, E; Allen, D; Porter, RJ; Wickramasinghe, SN; Porter, JB; Chinprasertsuk, S; Siripanyaphinyo, U; ... Wanachiwanawin, W; + view all (1998) Up-regulation of Fc gamma RI and its role in red cell destruction in thalassaemia. BRIT J HAEMATOL , 101 53 - 53.

Williamson, LM; Lowe, S; Love, EM; Cohen, H; (1998) The 1996/1997 annual SHOT report (on behalf of the serious hazards of transfusion steering group).

Y

Yong, K; Nicholls, CA; Fahey, A; Thomas, NSB; Inge, S; Watts, M; Linch, DC; (1998) Enhanced transendothelial migration of cord blood versus adult blood CD34(+) cells correlates with more rapid entry into cell cycle. BLOOD , 92 (10) 587A - 587A.

Yong, KL; Watts, M; Thomas, NS; Sullivan, A; Ings, S; Linch, DC; (1998) Transmigration of CD34(+) cells across specialized and nonspecialized endothelium requires prior activation by growth factors and is mediated by PECAM-1 (CD31). BLOOD , 91 (4) 1196 - 1205.

This list was generated on Sun May 19 04:45:28 2019 BST.